MindWalk Holdings (HYFT) Change in Cash (2023 - 2026)
MindWalk Holdings (HYFT) posted quarterly Change in Cash of -$2.0 million for Q2 2026, down 46.43% year-over-year from -$3.7 million in Q2 2025, and down 33.28% quarter-over-quarter from -$1.5 million in Q1 2026.
MindWalk Holdings (HYFT) Change in Cash (2023 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has reported Change in Cash for 4 consecutive years, with -$2.0 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Change in Cash fell 46.43% year-over-year to -$2.0 million; the TTM figure through Apr 2026 stood at $804439.1 (down 85.17% YoY), while the FY2026 annual figure was $873218.7, down 84.17% from the prior year.
- Change in Cash declined to -$2.0 million in Q2 2026 per HYFT's latest filing, from -$1.5 million in the prior quarter.
- Across five years, Change in Cash topped out at $8.0 million in Q4 2025 and bottomed at -$3.8 million in Q3 2025.
- Historically, Change in Cash has averaged -$128448.9 across 4 years, with a median of -$1.0 million in 2024.
- On a YoY basis, Change in Cash climbed as much as 4666.47% in 2025 and fell as far as 945.92% in 2025.
- MindWalk Holdings' Change in Cash stood at -$471996.1 in 2023, then surged by 62.76% to -$175749.3 in 2024, then soared by 4666.47% to $8.0 million in 2025, then slumped by 124.58% to -$2.0 million in 2026.
- Business Quant data shows HYFT's Change in Cash at -$2.0 million in Q2 2026, -$1.5 million in Q1 2026, and $8.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 427.25 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.97 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.94 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | -170.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -1.97 Mn |
| Jan 31, 2026 | -1.48 Mn |
| Oct 31, 2025 | 8.03 Mn |
| Jul 31, 2025 | -3.77 Mn |
| Apr 30, 2025 | -1.35 Mn |
| Jan 31, 2025 | 6.50 Mn |
| Oct 31, 2024 | -175,749.29 |
| Jul 31, 2024 | 445,490.30 |
| Apr 30, 2024 | -1.16 Mn |
| Jan 31, 2024 | -267,779.18 |
| Oct 31, 2023 | -471,996.09 |
| Jul 31, 2023 | -865,330.40 |
| Apr 30, 2023 | -2.26 Mn |
| Jan 31, 2023 | -3.00 Mn |